The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study

The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study

Purpose. To evaluate the effects of chlormadinone acetate (CMA), progesterone-derived antiandrogen, on lower urinary tract symptoms (LUTS) and erectile functions of benign prostatic hyperplasia (BPH). Methods. A multicenter, single-cohort prospective study was conducted. A total of 114 patients rece...

Full description

Bibliographic Details
Main Authors:	Kiyohide Fujimoto, Yoshihiko Hirao, Yasuo Ohashi, Yasuhiro Shibata, Kohzo Fuji, Hidenori Tsuji, Katsuhito Miyazawa, Mikinobu Ohtani, Ryoji Furuya, Eitetsu Boku
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Advances in Urology
Online Access:	http://dx.doi.org/10.1155/2013/584678

Similar Items

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy
by: Hidekazu Koike, et al.
Published: (2013-09-01)

Uso clínico de un nuevo progestógeno oral: Chlormadinone
by: Fernando del Corral, et al.
Published: (1963-12-01)

Contraception and hyperandrogenism. Clinical effects of a drug containing chlormadinone acetate
by: V N Prilepskaya, et al.
Published: (2015-08-01)

Medical aspects of oral contraceptives containing chlormadinone acetate in women with reproductive disorders
by: A L Unanyan, et al.
Published: (2013-04-01)

The effect of the combined contraceptive with chlormadinone acetate in the dermatological and psychosocial status of patients with acne
by: N E Vorobyova, et al.
Published: (2016-02-01)

Efficacy, safety, and patient acceptability of the combined chlormadinone acetate-ethinylestradiol oral contraceptive
by: Serena Ferrari, et al.
Published: (2010-09-01)

Active surveillance for nonmuscle invasive bladder cancer
by: Makito Miyake, et al.
Published: (2016-06-01)

The effect of chlormadinone acetate on odontogenic differentiation of human dental pulp cells: in vitro study
by: Se-Min Kim, et al.
Published: (2017-05-01)

Clinical utility of chlormadinone acetate (Lutoral™) in frozen‐thawed embryo transfer with hormone replacement
by: Yoshimasa Asada, et al.
Published: (2019-07-01)

Diagnosis and treatment of erectile dysfunction in patients with benign prostatic hyperplasia
by: S. N. Kalinina, et al.
Published: (2016-04-01)

Erectile function after endoscopic surgery for prostatic hyperplasia removal
by: P. V. Glybochko, et al.
Published: (2018-01-01)

Dose-Dependent Chlormadinone Acetate Can Suppress Premature LH Surge in Parallel with LH Value Reduction
by: Yuya Takeshige, et al.
Published: (2020-03-01)

Evaluation of metastatic potential of prostate cancer
by: Yoshitomo Chihara, et al.
Published: (2011-06-01)

Transverse testicular ectopia with disorders of sex development
by: Katsuya Aoki, et al.
Published: (2012-01-01)

Phytopreparations in complex treatment of patients with benign prostatic hyperplasia and erectile dysfunction
by: A. B. Bat’ko
Published: (2018-12-01)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
by: Oka AAG, et al.
Published: (2019-04-01)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
by: Yu Seob Shin, et al.
Published: (2019-05-01)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
by: Unnop Jaisamrarn, et al.
Published: (2018-04-01)

PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
by: Muhammed M. Qalawena, MD, et al.
Published: (2020-06-01)

A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction
by: Konstantinos Hatzimouratidis
Published: (2014-08-01)

Pathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction
by: Sidney Glina, et al.
Published: (2013-08-01)

New approaches to management of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia
by: S. I. Gamidov, et al.
Published: (2019-10-01)

Comparison of impact of monopolar versus bipolar resection of the prostate on erectile function in patients with benign hyperplasia of the prostate
by: G. El Shorbagy, et al.
Published: (2018-09-01)

Correlation between Fasting Glucose, Erectile Dysfunction, and Lower Urinary Tract Symptoms in Benign Prostate Hyperplasia Patients
by: Tommie Prasetyo, et al.
Published: (2017-01-01)

Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations
by: Alsaikhan B, et al.
Published: (2014-06-01)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
by: Gacci M, et al.
Published: (2013-04-01)

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction
by: Ahmed Abolyosr, et al.
Published: (2013-01-01)

A Case of Bisphosphonate-Related Osteonecrosis of the Jaw in a Patient with Subpontic Osseous Hyperplasia
by: Chiaki Tsuji, et al.
Published: (2017-01-01)

Periprostatic fat thickness measured on MRI correlates with lower urinary tract symptoms, erectile function, and benign prostatic hyperplasia progression
by: Bo Zhang, et al.
Published: (2021-01-01)

Association between vascular lesion and penile erection hardness in Japanese patients with erectile dysfunction
by: Keiichiro Hayashi, et al.
Published: (2018-01-01)

Disfunción sexual eréctil Sexual erectile dysfunction
by: Jorge Luis Sell Lluveras, et al.
Published: (2001-08-01)

Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
by: Chris Olesovsky, et al.
Published: (2016-08-01)

Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction
by: Zhongbao Zhou, et al.
Published: (2019-10-01)

Products of Oxidative Guanine Damage Form Base Pairs with Guanine
by: Katsuhito Kino, et al.
Published: (2020-10-01)

Generation, repair and replication of guanine oxidation products
by: Katsuhito Kino, et al.
Published: (2017-08-01)

Erectile Dysfunction
Published: (2015-01-01)

Erectile dysfunction
by: Leonardo Eiras Messina
Published: (2007-05-01)

The erectile dysfunction
by: Johan Eduardo Ardila Jaimes
Published: (2002-12-01)

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
by: Lee LK, et al.
Published: (2016-07-01)